NEW YORK, Sept. 03, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Centessa Pharmaceuticals plc (NASDAQ: CNTA) resulting from allegations that Centessa may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Centessa securities you […]

NEW YORK, Sept. 03, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the “Class Period”), of the important September 16, 2022 lead plaintiff deadline. SO WHAT: If you purchased TG Therapeutics securities […]